The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
about
The role of lipoxin A4 in endometrial biology and endometriosisInternational Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyKey mechanisms governing resolution of lung inflammationAnnexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and ClearanceDuality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad copResolution of inflammation in asthmaResolution of inflammation: an integrated viewBioactive lipids in Trypanosoma cruzi infectionRoles of resolvins in the resolution of acute inflammationResolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actionsDHA- and EPA-derived resolvins, protectins, and maresins in airway inflammationResolvin D1 binds human phagocytes with evidence for proresolving receptorsFunctional characterization of three mouse formyl peptide receptorsSerum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2Annexin A1 and glucocorticoids as effectors of the resolution of inflammationUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Annexin A1 regulates intestinal mucosal injury, inflammation, and repairResolution of acute inflammation in the lungPro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationMacrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repairResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsEliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injuryImproved survival and reduced vascular permeability by eliminating or blocking 12/15-lipoxygenase in mouse models of acute lung injury (ALI).Glucocorticoid-stimulated, transcription-independent release of annexin A1 by cochlear Hensen cellsEvidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formationFormyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.Neuroprotective effects of lipoxin A4 in central nervous system pathologies.Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.Specialized pro-resolving lipid mediators in the inflammatory response: An updateFormyl peptide receptors promotes neural differentiation in mouse neural stem cells by ROS generation and regulation of PI3K-AKT signalingNovel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery.Aspirin modulates innate inflammatory response and inhibits the entry of Trypanosoma cruzi in mouse peritoneal macrophages.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.
P2860
Q24564121-A0E3457B-7C0F-47EB-BC7A-03AECDBCCDAEQ24652940-5E9EE234-4918-43B8-9C94-3CADE2AF1C73Q26749606-DE27BF3F-CF13-4D63-87AA-76A324B41733Q26765186-DE3B54BD-3C60-41B5-91E4-55299DCE43CDQ26823530-A32D93AB-49A8-4744-9942-2F0CA03D9B63Q26823724-EF043F4A-23A8-46BA-AB1E-B72A72AD9995Q26852569-4DDA14BE-22DD-4AD0-90FA-860B64B35F69Q26866224-EE349645-24DE-4A83-A202-6115FF5D94C2Q28244502-5B4D8BCB-86DF-4C67-887A-013F207C184FQ28264433-B28723D5-796F-4545-96AF-F571D65CC122Q28269550-85E00710-41F2-4CD9-B56A-2227324649B3Q28270638-02BB2991-95FF-402B-85B7-39AAF5B9492EQ28279407-0ED8042C-A88E-48C8-8B33-E051A34D3D59Q28298733-E6CF9AB4-3A40-4EE7-AC57-E652B9F99B5FQ28304897-B65A2496-9F36-400A-8745-26C5274AE0AAQ28308192-2A663E16-4A0E-48B0-9B3E-848BBB09071AQ28594440-2E6EF865-5C56-43F7-A05A-20F0BADC4A70Q28652204-44B46346-0AA1-42DB-89E1-B68CF2F225CAQ28716294-2B774119-0C60-4309-88C5-D0E44019108AQ28731852-731ECEF9-D122-426A-B488-81F43611F00DQ29615694-5D869338-1C64-4CE8-B7D8-64A460B31236Q30418648-81BF89CE-574D-413C-84F5-548087CEA80AQ30434669-1BF2D7C9-77C2-4014-BAB2-2D77CA25A7C3Q30478346-54C97413-C1DD-48D8-B327-5F84363CB73CQ30504456-C5F26433-D97D-4174-95B5-83D564DC3385Q30514238-F7EC43AC-637A-4410-AEE2-688C68847E0EQ30764311-31225679-B0DD-4FAE-8806-27744BE9AF27Q30857083-440CD682-716B-4850-9218-6BA326332C2EQ31134484-DD8C499F-704C-4C3E-94CA-D11BF9804186Q33356900-2A614CF1-A965-4B1B-9373-EF4A6CE047DDQ33437576-2B8E6D4A-C16A-4A8F-A565-E870BE71FAD4Q33556241-80618B8E-FCB8-4A35-9998-3A0170B9F716Q33657562-E6B1D6D2-9A47-4AB4-8C9E-7A2676029A32Q33670941-72A72B02-CE92-4B6B-89DC-D099FF1B2271Q33683210-062C9EC5-DF99-474E-8507-0793E1EE0B11Q33695357-4997ADFF-4579-4172-BBCE-B6B84E8678F6Q33873763-D4E2DCF5-327A-41D8-983D-40AA8ED8D4D9Q33882297-5D26F661-DE1E-415F-B56F-422D905E46F3Q34095174-807F67D0-FD82-45BC-A30F-32FF1D54A9F0Q34113615-B2F73289-54DE-48CA-AE2A-D30A03A6DC04
P2860
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@ast
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@en
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@nl
type
label
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@ast
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@en
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@nl
prefLabel
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@ast
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@en
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@nl
P2093
P3181
P356
P1476
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
@en
P2093
Charles Brink
Charles N Serhan
Douglas W P Hay
G Enrico Rovati
Nan Chiang
Sven-Erik Dahlén
Takao Shimizu
P304
P3181
P356
10.1124/PR.58.3.4
P407
P577
2006-09-01T00:00:00Z